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SMRAsbestos has become one of the leading causes of death among occupational workers in the world. The associa-
tion between asbestos and cardiovascular disease is less reported. We performed ameta-analysis to quantify the
association between asbestos exposure and the mortality of cardiovascular related diseases. We performed a
systematic review in the PubMed database before December 2014. All cohort studies citing the standardized
mortality ratio (SMR) of cardiovascular related diseases in workers exposed to asbestos were collected. We
then calculated the pooled standardized mortality ratios of such diseases. Sixteen studies were included. The
combined results from all studies indicated the pooled SMR estimate for cardiovascular related diseases was
1.11 (95% CI, 1.01–1.22). Thismeta-analysis showed that asbestos exposure signiﬁcantly increased the risk of car-
diovascular related diseases in exposed workers.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
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Asbestos designates a group of naturally occurring silicate minerals
used commercially for their desirable physical properties. The harmful
effects of asbestos, however, have made it one of the world's leadingtandard errors; CI, Conﬁdence
isease; ODH, Other diseases of
diseases.
. This is an open access article undercauses of death among occupational workers. For example, asbestos
is one the most important occupational carcinogens, causing about
one half of all deaths from cancer linked to workplace exposure
(Driscoll et al., 2005). Currently, approximately 125 million workers
are exposed to asbestos worldwide and at least 107,000 of them die
from asbestos-related diseases every year (Burki, 2009). Despite
progressively more stringent regulations controlling occupational
exposure to asbestos, the asbestos-related disease epidemic has not
eased. It is well accepted that occupational exposure to asbestos pre-
dicts incidence of various diseases such as lung cancer, asbestosis, orme-
sothelioma (Selikoff & Seidman, 1991; Lotti, 2010) but the associationthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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disease is less clear.
Chronic inﬂammation processes plays an important role in the
pathogenesis of cardiovascular diseases (Libby, 2006). A growing body
of evidence suggests that long-term exposure to combustion particles
is associated with atherosclerosis and cardiovascular diseases (Hassing
et al., 2009; Hoek et al., 2013). In addition, silica, a non-combustion par-
ticle, has also been reported to increase mortality from cardiovascular
diseases in a cohort study of 74,040workers. The standardizedmortality
ratios of ischemic heart disease (1.65, 1.35–1.99) were signiﬁcantly
elevated among workers exposed to respirable silica concentrations
equal to or lower than 0.1 mg/m3 (Chen et al., 2012). Asbestos, a kind
of silicate, can also induce a strong inﬂammatory reaction in animal
models and promotes atherogenesis (Gardner et al., 1986; Dogra &
Donaldson, 1995; Dostert & Petrilli, 2008; Cyphert et al., 2012). How-
ever, little attention has been given to adverse health effects of
asbestos exposure on cardiovascular system. It could be hypothesized
that asbestos may be a risk factor of cardiovascular events. Certainly,
some cohort studies have suggested an association between the
increased risk of cardiovascular diseases and exposure to asbestos
(Loomis et al., 2009; Harding et al., 2012) but there are also quite a
number of studies which provide negative results (Battista et al.,
1999; Sichletidis et al., 2009). The mortality of cardiovascular events
in these studies which focus on the major asbestos-related diseases,
namely lung cancer or mesothelioma, was not studied in depth. The
potential role of chance, confounding factors, and other forms of bias
were not taken into account. For this reason, this meta-analysis of
the epidemiologic evidence was conducted. Our objective was to
quantify the association between asbestos exposure and the mortal-
ity of cardiovascular related diseases.
Materials and methods
Search strategy
All published studies citing the SMR of cardiovascular diseases in
workers exposed to asbestos were collected by conducting a search on
PubMed before December 2014. The following key words were used:
“cardiovascular diseases,” “heart diseases,” “mortality,” “incidence,”
“asbestos,” “crocidolite,” “chrysotile,” “amphibole,” and “amosite.” In
addition, we searched all the references of collected studies to identify
additional relevant reports. Individual studies and the data extracted
were reviewed independently by two authors using a standardized
form. We screened titles ﬁrst and then a second screening on abstracts
and full-text was considered. Only English language full-text papers
were included that reported either SMR or observed and expected
deaths in cohort study. The studies were excluded if there were not suf-
ﬁcient data to provide for the determination of standardized mortality
ratio and conﬁdence interval. If different opinions on including or
excluding one paper appeared, the disagreement was resolved by
voting among all authors. If a study made a stratiﬁed analysis based
on gender, type of cardiovascular related diseases or kind of asbestos
exposed, the results of stratiﬁcation analysis were set as new literatures
to be included. Each study was reviewed critically and the following
data was extracted: (1) Author of the paper and year of publication,
(2) Type of cardiovascular related disease, (3) Country of origin,
(4) Type of industry and asbestos exposed in the study, (5) Number of
the cohort and the information of gender, (6) Follow-up of study partic-
ipants, (7) The SMR and the conﬁdence interval for the SMR, (8) Assess-
ment of asbestos exposure and (9) All-cause mortality. Details of the
papers were summarized in Table 1.
Statistical analysis
Statistical analysis was conducted on natural logarithm of the
SMR, the ln-SMR, because its sampling distribution more closelyapproximates a normal distribution proves more useful analyzing a
combination of papers on different participants. Based on the reported
conﬁdence interval, we calculated the standard errors (SEs) for the
ln(SMR) given by the formula SE = [ln(upper limit) − ln(lower
limit)] / 3.92. Overall pooled SMR estimates and corresponding 95%
CIs were calculated using ﬁxed-effects (Manel–Haenszel method) and
random-effects (DerSimonian and Laird method) methods (Harris,
2008). Because of the signiﬁcant amount of heterogeneity, we only pre-
sented the random-effects estimates. Meta-regression techniques were
used to determine the extent to which variables following might
explain heterogeneity: gender (male, female, or gender mixed), geo-
graphic region (United States vs. Europe), type of industry (textiles,
mining, cement, mixed, or others) magnitude of the SMR for all
causes (≤1.0 or N1.0), type of asbestos (crocidolite, chrysotile, am-
phibole, amosite, or mixed), type of cardiovascular diseases (circula-
tory diseases, ischemic disease, pulmonary heart disease, all heart
diseases, or others), and follow-up period (b35 or ≥35 years). To assess
heterogeneity not only among studies but also between sub groups, we
used the I2 and Q statistics. For I2, a value N25% was considered a mea-
sure of heterogeneity; for the Q statistic, PQ b 0.10 indicated signiﬁcant
heterogeneity(Higgins & Thompson, 2002). Paper bias was assessed
by visual inspection of Begg's funnel plots and investigated using
Egger's regression asymmetry method formally. We deﬁned statistical
signiﬁcance as p-value b 0.05 for all analyses except for the heterogene-
ity. All meta-analyses were completed with Stata software (Version
10.0; StataCorp, College Station, TX).
Results
Literature search
A total 1124 unique citations were initially retrieved from the
PubMed database. The majority of these were excluded after the ﬁrst
screening on titles or abstracts, mainly because they were not cohort
studies or not English papers, no SMR of cardiovascular related diseases
reported, or not relevant to our research. After review of 29 full-text
papers, 10 studies were excluded because of incomplete conﬁdence
interval information. For three studies in which the data analysis of
the cohort was updated, we chose the most recent (Musk et al., 2008;
Pira et al., 2009; Harding et al., 2012) and excluded 3 papers from
the previous report. Finally, 16 studies were included in our analysis
(Fig. 1).
Study characteristics
The characteristics of the 16 studies included are given in Table 1.
Nine of the studies were conducted in European countries (United
Kingdom, Denmark, Italy, Lithuania, Greece), four in North America
(United States, Canada), and one was carried out in China, Australia
and South Africa respectively. Five of the sixteen studies included data
stratiﬁed by gender (Gardner et al., 1986; Smailyte et al., 2004; Hein
et al., 2007; Harding et al., 2012;Wang et al., 2013). Six cohorts only in-
cluded female workers and eight cohorts only were conducted onmale
workers, seven included both males and females. Of the sixteen papers
analyzed, nine reported circulatory diseases (CD), seven reported ische-
mic heart disease (IHD), two reported pulmonary heart diseases (PHD),
four reported all heart diseases (AHD), and three reported other dis-
eases of the heart (ODH). The industries of asbestos exposure involved
in analysis includedmining, manufacture of textiles, cement produc-
tion and construction.
Meta-analysis
Fig. 2 presents the SMR and 95% CIs of individual studies and the
pooled SMR results from the random-effects model. The average pooled
SMR for cardiovascular related diseases among asbestos exposed
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(P b 0.05). Signiﬁcant heterogeneitywas investigated among the studies
(I2 = 93.5%; P b 0.01). Visual inspection of Begg's funnel plots did not
conﬁrm substantial asymmetry (Fig. 3). The Egger linear regression
test and the Begg rank correlation test showed no evidence of publica-
tion bias among papers included (Egger, P= 0.36; Begg, P=0.83). Het-
erogeneity was further investigated to determine potential explanatory
factors. Subgroup analyses were conducted by the following covariates:
gender, type of asbestos, geographic region, type of industry, type of
diseases, follow-up period in years and SMR for all causes.
The pooled SMR for studies in males and females were 1.10 (95% CI,
0.8–1.53) and 1.08 (95% CI, 0.92–1.25) separately with signiﬁcant het-
erogeneity (I2 = 97.6, P b 0.01; I2 = 72.6, P b 0.01). The pooled SMR
for studieswithmixed gender was 1.15 (95% CI, 1.02–1.30), with signif-
icant heterogeneity (I2 = 91.4, P b 0.01). The pooled SMR for studies on
European populations was 0.88 (95% CI, 0.75–1.02) with signiﬁcant
heterogeneity (I2 = 92.3, P b 0.01). For workers in USA, the pooled
SMR was 1.20 (95% CI, 1.09–1.32) with signiﬁcant heterogeneity
(I2 = 83.4, P b 0.01). The pooled SMR of results from other countries
was 1.75 (95% CI, 1.17–2.60) with signiﬁcant heterogeneity (I2 = 96.8,
P b 0.01). The results suggest that pooled SMR from cardiovascular relat-
ed diseases in asbestos-exposedworkers in the USA and other countries
including South Africa, Australia and China was higher than that in the
general population (P b 0.01).
The SMRs from cardiovascular related diseases varied in people
exposed to different types of asbestos. Our results showed that SMRs
from such diseases was higher in workers exposed to chrysotile and
amphibole (1.23〔95% CI, 1.07–1.41〕; 1.26〔95% CI, 1.02–1.56〕)
when compared with those exposed to crocidolite (0.80〔95% CI,
0.74–0.86〕). The differences were statistically signiﬁcant. The
SMRs from cardiovascular related diseases in workers exposed to
mixed asbestos was 0.81 (95% CI, 0.6–1.08). Except for crocidolite
studies (I2 = 0, P = 0.45), other three subgroups had signiﬁcant
heterogeneity.
The types of industry inﬂuence the SMRs fromcardiovascular related
diseases in asbestos-exposed workers. The SMR from such diseases of
workers in textile (1.41〔95% CI, 1.16–1.70〕) was signiﬁcant higher
than that of workers in cement (0.82〔95% CI, 0.70–0.98〕). The results
in both industries had signiﬁcant heterogeneity. The pooled SMR were
1.13 (95% CI, 0.91–1.39) and 1.07 (95% CI, 0.88–1.30) separately for
workers in mining and other industries with signiﬁcant heterogeneity
(I2 = 87.9, P b 0.01; I2 = 93.2, P b 0.01).
The SMRs from various cardiovascular related diseases were pooled
in this study. Signiﬁcantly elevated SMRs were observed from pulmo-
nary heart diseases, (SMR 4.13, 95% CI, 1.55–10.98), and other heart
diseases (SMR 1.32, 95% CI, 1.14–1.53). The SMRs from circulatory dis-
eases, all heart diseases and ischemic heart diseases were 0.99 (95% CI,
0.88–1.11), 0.99 (95% CI, 0.86–1.14), and 1.04 (95% CI, 0.82–1.32)
respectively. All of these pooled SMRs had signiﬁcant heterogeneity.
Follow-up period in years was not a signiﬁcant predictor of the
pooled SMR, both studies with a follow-up time of less than 35 years
and those following up after 35 years ormore did not appear to be asso-
ciated with an increase in cardiovascular related disease mortality (1.10
(95% CI, 0.98–1.24); 1.13 (95% CI, 0.98–1.31)) with signiﬁcant het-
erogeneity. Studies that reported an SMR for all causes N 1 (1.20
(95% CI, 1.09–1.33)) compared with other studies (0.84 (95% CI, 0.68–
1.05)) had a larger pooled SMR, a difference which was statistically
signiﬁcant.
To explain the heterogeneity, we conducted a meta-regression and
found geographical region and type of asbestos might be effect factors
(P b 0.05). However, the combination of these two subgroups did not
solve the problem of heterogeneity. Thus, we mixed the two covariates
to recombine again. The pooled SMR of chrysotile exposure in European
studies, North American studies, and studies in other countries were
0.98 (95% CI, 0.92–1.04), 1.23 (95% CI, 1.18–1.28), and 0.80 (95% CI,
0.74–0.86) respectively with non-signiﬁcant heterogeneity. Anotherfour groups including studies on exposure to other asbestos types out-
side of Europe and North America, North American studies on exposure
to other asbestos types, European studies on exposure to mixed asbes-
tos and studies on exposure to chrysotile outside of Europe and North
America still had signiﬁcant heterogeneity, with pooled SMRs of 1.33
(95% CI, 1.05–1.68), 1.14 (95% CI, 0.77–1.69), 0.81 (95% CI, 0.60–1.08)
and 3.13 (95% CI, 0.56–17.48) respectively. Based on the result of visual
impression of heterogeneity across all the studies, a study byMusk et al.
(2008), conducted in Australia, and a study by Menegozzo et al. (2011)
were the biggest contributors to inter-study variation. The pooled SMR
for cardiovascular related diseases excluding these two studieswas 1.17
(95% CI, 1.07–1.28). We mixed geographical region and type of disease
to group when excluding the two studies above mentioned. Heteroge-
neity was eliminated except the groups of ischemic heart diseases in
Europe and North America.
Discussion
The investigation of this meta-analysis showed that asbestos
exposure could increase the risk of cardiovascular related diseases
in exposed workers. The possible biological mechanisms might be
indirect toxic effect of persistent inﬂammatory reaction induced by
inhaled asbestos ﬁbers in lung tissues. Some inﬂammatory media-
tors could enter blood vessel and transfer to heart. In addition,
impaired lung function could lead to episodes of hypoxemia which
would increase the risk of mortality from cardiovascular related dis-
eases (Boor et al., 2009; Lee et al., 2011). However, there was signif-
icant heterogeneity in the papers included in the analysis. This may
be explained by the differences in study designs, the nature of the
cohort population, methodologies of exposure assessment, and other
differences. The results from our studies clearly showed that geo-
graphical region and type of disease might be what affected the
heterogeneity the most.
The risk of cardiovascular related diseases varied inworkers exposed
to different type of asbestos. Among studies involving chrysotile, the
highest risks of cardiovascular related disease mortality were seen
among asbestos textile workers compared to the lower risks which
were observed among workers of mining and cement production. This
could be explained by the higher concentration of exposure in textile
manufacturing (Hughes & Weill, 1986). In addition, some samples of
chrysotile from the mines contained contaminations of ﬁbrous silicate,
which has some characteristics in common with crocidolite, including
the oxidant activity and cell toxicity (Turci et al., 2005). This is consis-
tent with the result that exposure to crocidolite asbestos might not in-
crease the risk of cardiovascular related diseases mortality. For studies
investigating chrysotile, workers had shown lower rates of cancer
than those exposed to other types of asbestos (Ohlson & Hogstedt,
1985). However, cardiovascular disease, a kind of chronic disease, was
not like cancer and had longer survival, which could explain why
SMRs of cardiovascular related diseases in chrysotile studies were
higher.
Although the SMRs in the studies on chrysotile-exposed workers
were generally higher in studies on other asbestos types, the effects of
chrysotile exposure in different geographical regions were not the
same. The studies conducted in developing countries like South Africa
and China obtained a higher SMR compared to those in Europe or
North America. There are several possible explanations. First of all,
the protective measures were quite different. In developed countries,
industries have enough economic ability to provide a greater degree of
occupational safety and workers may be more conscious about safe
production practices. It is therefore not surprising that fewer deaths
occurred in these groups. The second explanation is the different expo-
sure dose. In developing countries, the ﬁber concentrations in working
environments were quite high (Sluis-Cremer et al., 1992). Another im-
portant factor for explaining the geographical difference in cardiovascu-
lar related diseasemortality is the type of chrysotile. Therewas less than
Table 1
Study characteristics.
Study Disease Country Industry type Asbestos type N Follow-up
time
SMR 95%CI Exposure assessment SMR of all
causes
Gardner et al. (1986) Circulatory diseases United
Kingdom
Cement Chrysotile 1510 male 1941–1983 0.87 0.74–1.01 Occupational environment monitoring and




Cement Chrysotile 657 female 1941–1983 1.16 0.87–1.51 Occupational environment monitoring and
assessment of industry job titles
0.92
Raffn et al. (1989) Circulatory diseases Denmark Cement Chrysotile 8580 (7996 male,
584 female)
1928–1984 1.01 0.92–1.11 Occupational environment monitoring 1.18
Sluis-Cremer et al. (1992) Ischemic heart disease South Africa Mining Amphibole 7317 1946–1980 1.11 0.99–1.23 Occupational environment monitoring and




South Africa Mining Amphibole 7317 1946–1980 2.24 1.07–4.12 Occupational environment monitoring and
assessment of industry job titles
1.37
Ischemic heart disease South Africa Mining Amosite 3212 1946–1980 1.16 1.02–1.32 Occupational environment monitoring and




South Africa Mining Amosite 3212 1946–1980 3.17 1.49–5.95 Occupational environment monitoring and
assessment of industry job titles
1.42
Ischemic heart disease South Africa Mining Crocidolite 3430 1946–1980 0.99 0.84–1.77 Occupational environment monitoring and




South Africa Mining Crocidolite 3430 1946–1980 1.15 0.2–3.61 Occupational environment monitoring and
assessment of industry job titles
1.27
Levin et al. (1998) All heart diseases United States Construction Amosite 753 male 1954–1993 1.18 0.9–1.52 Environmental surveys and historical
records
1.66
Germani et al. (1999) Circulatory diseases Italy Mixed Mixed (chrysotile and
amphiboles)
631 female 1980–1997 0.89 0.7–1.12 Diagnoses of asbestosis as proxy for
asbestos exposure
1.58
Ischemic heart diseases Italy Mixed Mixed (chrysotile and
amphiboles)
631 female 1980–1997 0.53 0.28–0.93 Diagnoses of asbestosis as proxy for
asbestos exposure
1.58
Circulatory diseases Italy Textile Chrysotile 276 female 1980–1997 0.93 0.65–1.3 Diagnoses of asbestosis as proxy for
asbestos exposure
1.68
Ischemic heart diseases Italy Textile Chrysotile 276 female 1980–1997 0.43 0.12–1.09 Diagnoses of asbestosis as proxy for
asbestos exposure
1.68
Circulatory diseases Italy Cement Mixed (chrysotile and
amphiboles)
278 female 1980–1997 0.82 0.58–1.14 Diagnoses of asbestosis as proxy for
asbestos exposure
1.43
Ischemic heart diseases Italy Cement Mixed (chrysotile and
amphiboles)
278 female 1980–1997 0.69 0.3–1.35 Diagnoses of asbestosis as proxy for
asbestos exposure
1.43
Battista et al. (1999) Circulatory diseases Italy Construction Mixed (chrysotile and
crocidolite)
734 male 1945–1997 0.73 0.58–0.92 – 1
Smailyte et al. (2004) Circulatory diseases Lithuania Cement Chrysotile 1972 male 1978–2000 1 0.9–1.2 Occupational environment monitoring and
assessment of industry job titles
1
Circulatory diseases Lithuania Cement Chrysotile 815 female 1978–2000 1 0.7–1.4 Occupational environment monitoring and
assessment of industry job titles
1











Study Disease Country Industry type Asbestos type N Follow-up
time
SMR 95%CI Exposure assessment SMR of all
causes
Hein et al. (2007) All heart diseases United States Textile Chrysotile 3072 (1807 male,
1265 female)
1940–2001 1.2 1.1–1.3 Occupational environment monitoring and
assessment of industry job titles
1.33
Ischemic heart diseases United States Textile Chrysotile 3072 (1807 male,
1265 female)
1940–2001 1.2 1.1–1.32 Occupational environment monitoring and
assessment of industry job titles
1.33
Other diseases of the
heart
United States Textile Chrysotile 3072 (1807 male,
1265 female)
1940–2001 1.27 1.01–1.58 Occupational environment monitoring and
assessment of industry job titles
1.33
Circulatory diseases United States Textile Chrysotile 3072 (1807 male,
1265 female)
1940–2001 1.28 1.1–1.47 Occupational environment monitoring and
assessment of industry job titles
1.33
All heart diseases United States Textile Chrysotile 1265 female 1940–2001 1.12 0.97–1.29 Occupational environment monitoring and
assessment of industry job titles
1.29
Ischemic heart diseases United States Textile Chrysotile 1265 female 1940–2001 1.11 0.94–1.30 Occupational environment monitoring and
assessment of industry job titles
1.29
Other diseases of the
heart
United States Textile Chrysotile 1265 female 1940–2001 1.34 0.92–1.88 Occupational environment monitoring and
assessment of industry job titles
1.29
Circulatory diseases United States Textile Chrysotile 1265 female 1940–2001 1.25 0.99–1.56 Occupational environment monitoring and
assessment of industry job titles
1.29
Musk et al. (2008) Circulatory diseases Astralia Mining Crocidolite 6943 (6498 male,
445 female)
1943–2000 0.79 0.73–0.85 Occupational environment monitoring and
assessment of industry job titles
1.13
Sichletidis et al. (2009) Circulatory diseases Greece Cement Chrysotile 317 1968–2006 0.77 0.49–1.16 Occupational environment monitoring and
assessment of industry job titles
0.71
Loomis et al. (2009) All heart diseases United States Textile Chrysotile 5770 (3975 male,
1795 female)
1950–2003 1.32 1.22–1.42 Occupational environment monitoring and
assessment of industry job titles
1.47
Pira et al. (2009) Ischemic heart diseases Italy Mining Chrysotile 1056male 1946–2003 0.93 0.71–1.2 Occupational environment monitoring and
assessment of industry job titles
1.43
Larson et al. (2010) Ischemic heart diseases Canada Vermi-culite Amphibole 1862 1946–2006 0.7 0.6–0.8 Occupational environment monitoring and
assessment of industry job titles
1.3
Other diseases of the
heart
Canada Vermi-culite Amphibole 1862 1946–2006 1.5 1.2–1.8 Occupational environment monitoring and
assessment of industry job titles
1.3
Circulatory diseases Canada Vermi-culite Amphibole 1862 1946–2006 1.4 1.2–1.6 Occupational environment monitoring and
assessment of industry job titles
1.3
Menegozzo et al. (2011) All heart diseases Italy Cement Mixed (crocidolite,
chrysotile and asmosite)
1247 male 1965–2005 0.57 0.48–0.68 Occupational environment monitoring and
assessment of industry job titles
0.93
Ischemic heart diseases Italy Cement Mixed (crocidolite,
chrysotile and asmosite)
1247 male 1965–2005 0.47 0.34–0.64 Occupational environment monitoring and
assessment of industry job titles
0.93
Harding et al. (2012) Ischemic heart diseases United
Kingdom
Mixed Mixed 94403 male 16 1.28 1.24–1.32 Personal interview using questionnaire
about occupational exposure to asbestos
1.42
Ischemic heart diseases United
Kingdom
Mixed Mixed 4509 female 1971–2005 1.61 1.38–1.87 Personal interview using questionnaire
about occupational exposure to asbestos
1.42
Wang et al. (2013) Pulmonary heart
disease
China Textile Chrysotile 577 male 1972–2008 13.09 9.46–18.12 Occupational environment monitoring and




China Textile Chrysotile 277 female 1972–2008 8.33 2.29–30.39 Occupational environment monitoring and
assessment of industry job titles
0.82
Other diseases of the
heart
China Textile Chrysotile 577 male 1972–2008 0.87 0.52–1.43 Occupational environment monitoring and
assessment of industry job titles
1.31
Other diseases of the
heart
China Textile Chrysotile 277 female 1972–2008 1.02 0.35–2.99 Occupational environment monitoring and











Fig. 1. Study ﬂow chat.
Fig. 2. Forest plot shows association between cardiovascular related diseases and occupational
size of the box being proportional to theweight given to the study.Weights are from random-ef
SMR is displayed as a diamond.
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sample (Tossavainen et al., 2000). The chrysotile from Russia was
much thicker than that from Canada and it could be cleared from the
lungs within months. This Russian chrysotile seemed to be of lesser
risk than other types of chrysotile. In developed countries, most asbes-
tos industries used this chrysotile from Russia.
The analysis of disease subgroups showed a fairly high SMR of
pulmonary heart disease. This may also help in explaining the bio-
logical mechanisms by which asbestos exposure could increase the
risk of cardiovascular related diseases. Because all heart diseases in-
clude pulmonary heart disease, the SMR of all heart diseases was also
above the national average with statistical signiﬁcance. Additionally,
cerebrovascular disease and hypertensive disease were inside the
range of circulatory diseases and were strongly inﬂuenced by con-
founding factors such as genetic background and life habits. It has
been reported that the mortality of cerebrovascular disease and
hypertensive diseasewere not increased in cohort exposure to asbestosexposure to asbestos. Each triangle in box represents an individual SMR estimate with the
fectsmodel. The lines represent the 95% CI for the point estimate in each study. The pooled
Fig. 3. Begg's funnel plot with pseudo 95% CIs.
926 Y. Rong et al. / Preventive Medicine Reports 2 (2015) 920–926(Germani et al., 1999). Our results also indicated that there was no
explicit relationship between asbestos exposure andmortality of ische-
mic heart diseases.
Our meta-analysis has a number of limitations need to be taken
into account when investigating the association between asbestos
exposure and cardiovascular related diseases. These limitations
depend on the information that papers include in the analysis. A
number of studies lacked details of exposure assessment. When
studies used job titles to classify exposure, misclassiﬁcation is a pos-
sibility. In addition, differences in the deﬁnitions of exposure dura-
tion and latency of asbestos exposure measures could prevent a
uniﬁed evaluation of a dose-response relationship. Moreover, per-
sonal interview using questionnaires (Harding et al., 2012) were
more likely to be inﬂuenced by individual biases, as cases tended to
report their exposures more precisely. Other unknown occupational
hazards might be not accounted for in the individual studies and
could overestimate the risk of asbestos exposure. A further limitation
was its inability to assess nonoccupational risk factors for cardiovascular
related diseases like smoking status, living habits, diet, alcohol use or
medications. Finally, some published studies regarding asbestos expo-
sure failed to report cardiovascular related diseases or only reported
the results for SMRs of diseases but no CIs. These studies could be a
potential concern.Conclusion
This meta-analysis showed that asbestos exposure signiﬁcantly
increased the risk of cardiovascular related diseases in exposed
workers.Conﬂict of interests
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